Exhibit 5.1
| | |
| | Reference: 99472/5 |
August 29, 2023 | | |
enGene Holdings Inc. 7171 Frederick Banting Saint-Laurent, Québec H4S 1Z9 | | |
RE: enGene Holdings Inc.—Registration Statement on Form S-4
Dear Sirs and Mesdames:
We have acted as Canadian counsel to enGene Holdings Inc., a corporation governed by the Canada Business Corporations Act (the “Corporation”), in connection with the transactions contemplated by a business combination agreement dated May 16, 2023 (the “Business Combination Agreement”) by and among Forbion European Acquisition Corp., (“FEAC”), Can Merger Sub, Cayman Merger Sub, and the Corporation. The Corporation filed a registration statement on Form S-4 with the United States Securities and Exchange Commission (the “SEC”) on August 9, 2023 (the “Registration Statement”), relating to the registration under the U.S. Securities Act of 1933, as amended (the “Securities Act”), of (i) 27,090,013 common shares in the capital of the Corporation (“Common Shares”), 14,023,496 of which are issuable pursuant to the Cayman Merger and 13,066,517 are issuable pursuant to the Plan of Arrangement (the “Arrangement Shares”); (ii) 6,896,099 Common Shares (the “Warrant Shares”) issuable pursuant to and in accordance with the warrants to purchase Common Shares (the “Warrants”), 4,216,666 of which are issuable in respect of 4,216,666 FEAC Public Warrants, and 2,679,432 are issuable in respect of enGene Warrants issued to the lenders of the Convertible Bridge Financing and governed by the warrant agreement dated as of December 9, 2021 (the “Warrant Agreement”) by and between FEAC and Continental Stock Transfer & Trust Company, as trustee (the “Trustee”), as the same will be as amended, assigned and assumed pursuant to the warrant assignment, assumption and amendment agreement (the “Warrant Amendment Agreement” and, together with the warrant agreement, the “Warrant Documents”) to be entered into by and among the Corporation and the Trustee to be effective following the closing (the “Closing”) of the transactions contemplated by the Business Combination Agreement; and (iii) the Warrants.
Terms used in this opinion that are defined in the Business Combination Agreement, and are not otherwise defined herein, have the same meanings herein as in the Business Combination Agreement.
Materials Reviewed
In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of each of the following documents:
| (a) | the Registration Statement and such matters of fact and questions of law as we have considered appropriate for the purposes of this letter; |
| (b) | the Business Combination Agreement included in the Registration Statement; |